Class II
Ongoing
Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 6…
Why: CGMP Deviations
- Company
- Baxter Healthcare Corporation
Deerfield, IL, United States - Reported
- Sep 9, 2026
- Recall started
- Aug 6, 2026
- Where sold
- US Nationwide; Puerto Rico; and Chile.
- Amount
- N/A
- Full product description
- Clindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose Container, Rx only, Sterile Nonpyrogenic, Manufactured by: Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 43066-995-24.
- Lots / codes affected
- Lot # NC194068, Exp Date: 10/29/2027.
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.